Cargando…

Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review

BACKGROUND: China’s National Reimbursement Drug List (NRDL) has become the primary route for drug reimbursement in China. More recently, the authority has made pharmacoeconomic evaluation an integral part of the application for NRDL inclusion. The underlying financial conflict of interests (FCOI) of...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Zixuan, Huang, Xianqin, Chen, Dingyi, Wang, Guoan, Zhu, Yuezhen, Li, Huangqianyu, Han, Sheng, Shi, Luwen, Guan, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689407/ https://www.ncbi.nlm.nih.gov/pubmed/38030227 http://dx.doi.org/10.1136/bmjgh-2023-012780

Ejemplares similares

The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data
por: Yang, Yu, et al.
Publicado: (2023)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
por: Zhang, Yichen, et al.
Publicado: (2021)

Benzodiazepine Receptor Agonists Prescribing for Insomnia Among Adults in Primary Health Care Facilities in Beijing, China
por: Fu, Mengyuan, et al.
Publicado: (2023)

Effect of the full coverage policy of essential medicines on medication adherence: A quasi-experimental study in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2022)

Appropriate use of antibiotics for acute respiratory infections at primary healthcare facilities in China: a nationwide cross-sectional study from 2017 to 2019
por: Fu, Mengyuan, et al.
Publicado: (2023)

Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
por: Wu, Di, et al.
Publicado: (2022)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China
por: Mingge, Xia, et al.
Publicado: (2023)

The importance of publishing research protocols for pharmacoeconomic studies
por: Dane, Aniek, et al.
Publicado: (2023)

Emergency Physician Reimbursement: Getting Shortchanged or Shrewdly Negotiating?
por: Venkatesh, Arjun K., et al.
Publicado: (2020)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

Pharmacoeconomic Analysis of Antiepileptic Reimbursement for Neuropathic Pain in Bosnia and Herzegovina – Budget Impact Analysis of Pregabalin
por: Catic, Tarik, et al.
Publicado: (2018)

Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship
por: McPartland, John M.
Publicado: (2009)

Sponsorship bias and quality of randomised controlled trials in veterinary medicine
por: Wareham, K. J., et al.
Publicado: (2017)

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
por: Zhu, Hong, et al.
Publicado: (2022)

Effectiveness of hierarchical medical system policy: an interrupted time series analysis of a pilot scheme in China
por: Hu, Huajie, et al.
Publicado: (2023)

Project sponsorship
por: Englund, Randall L, et al.
Publicado: (2015)

Pharmaceutical Sponsorship Bias Influences Thrombolytic Literature in Acute Ischemic Stroke
por: Radecki, Ryan Patrick
Publicado: (2011)

How to Assess the Epistemic Wrongness of Sponsorship Bias? The Case of Manufactured Certainty
por: Leefmann, Jon
Publicado: (2021)

Industry sponsorship bias in cost effectiveness analysis: registry based analysis
por: Xie, Feng, et al.
Publicado: (2022)

Reporting quality of economic evaluations of the negotiated Traditional Chinese Medicines in national reimbursement drug list of China: A systematic review
por: Yan, Juntao, et al.
Publicado: (2023)

The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China
por: Hu, Lin, et al.
Publicado: (2022)

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
por: Huang, Cong, et al.
Publicado: (2021)

Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2022)

An Empirical Exploration of Sports Sponsorship: Activation of Experiential Marketing, Sponsorship Satisfaction, Brand Equity, and Purchase Intention
por: Hsiao, Chun-Hua, et al.
Publicado: (2021)

The Sponsorship Seeker's Toolkit
por: Skildum-Reid, Kim
Publicado: (2014)

Strategies for Project Sponsorship
por: James, Vicki
Publicado: (2013)

The Nuffield Sponsorship Ends
Publicado: (1991)

Editorial: Sponsorship for Survival
Publicado: (1981)

The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
por: Wettstein, Dominik J., et al.
Publicado: (2020)

Sponsorship Bias in Clinical Trials in the Dental Application of Probiotics: A Meta-Epidemiological Study
por: Hu, Qin, et al.
Publicado: (2022)

Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014)

Principles of pharmacoeconomics /
Publicado: (1996)

Corporate sponsorship for museums in times of crisis
por: Biraglia, Alessandro, et al.
Publicado: (2021)

How reliable are ICER’s results published in current pharmacoeconomic literature? The controversial issue of price confidentiality
por: Russo, Pierluigi
Publicado: (2022)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
por: Macabeo, Bérengère, et al.
Publicado: (2023)

The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China
por: Guo, Zhigang, et al.
Publicado: (2017)

Mentorship, Sponsorship, and the Emerging Role of Social Media
por: Whitson, Bryan A.
Publicado: (2022)

Pharmacoeconomics in COPD: lessons for the future
por: Starkie, Helen J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1vik25229dlb8lbjibv61cfri7